Company
BTG
LON:BTG
BTG is a growing life sciences company focused on the development and commercialisation of pharmaceuticals targeting neurological and other disorders.
46 stories
Investments and investor services
FTSE 100 closes higher Monday, just, as traders sit on hands
Footsie closed around 11 points higher at 7,357 at the start of the week, while mid-cap cousin FTSE 250 gained over 39 points
Archive
Federal Reserve rate decision to dominate in week ahead, with BoE meeting likely to be dull
The corporate diary is fairly sparse, but there are some bright spots, notably updates from refocused blue chip hotels group Whitbread and housebuilder Berkeley Group
Investments and investor services
FTSE 100 closes in the red as trade tensions and Brexit confusion rumble on
The UK index of leading shares closed down nearly 38 points at 7,310
Archive
Still no opportunities to sell in May, with Royal Mail and M&S set to deliver updates
The Week Ahead will also bring news from power firm SSE and water groups Severn Trent and United Utilities, plus the latest UK inflation and retail sales numbers
Jefferies downgrades BTG as it rules out bidding war for the UK pharma group
Analysts at the US investment bank said in a note that they don’t expect any other bidders to come forward, so have cut their rating and target to reflect that
Webis weak on limited California license renewal; Kier Group drops on cash call
A look at some winners and losers in the UK equity market on Friday
FTSE 100 closes lower as G20 summit begins and trade worries continue; housebuilders fall
The premier index of UK shares finished down nearly 59 points at 6,980. Mid-cap cousin FTSE 250 shed over 128 points at 18,480.
BTG lifts full-year guidance again, this time on spike in sales of its snake bite anti-venom
The upgrade came alongside half-year results, in which BTG reported a 12% in revenue and a 35% jump in adjusted operating profits
Investments and investor services
FTSE 100 flatlines at close as sterling gains on Brexit optimism
The UK blue-chip benchmark closed up 0.68 at 7,053, while the FTSE 250 added over 174 points at 18,985
Archive
Taylor Wimpey and Vodafone to lead the way on a busy Tuesday in the City
The City diary is filled to the brim, with updates expected from Taylor Wimpey, McCarthy & Stone, Vodafone, Premier Foods, Experian and many more
Archive
Housebuilders to take centre stage again after Persimmon boss drama
The week ahead includes trading updates from Bovis Homes and Taylor Wimpey, full year results from McCarthy & Stone, interims from Royal Mail, Vodafone and Premier Foods along with a batch of UK data
BTG upgrades full-year sales forecasts following strong portfolio performance in first half
The FTSE 250 healthcare firm said it was upgrading its product sales forecasts for the combined Vascular and Oncology portfolios to 15%-17% growth for the year
BTG snaps up medical device maker Novate for up to US$150mln
Novate has developed Sentry, a vascular device designed to manage blood clots, which was recently deemed safe and effective by US regulators
Investments and investor services
FTSE 100 closes higher, bolstered by sterling's fall; rate rise doubts
The index of leading UK shares closed up just shy of 50 points higher at 7,676, while the FTSE 250 was also up
As Ryanair's struggles continue can easyjet look to the blue skies?
Easyjet and Severn Treant are among the key names in the diary for Wednesday.
Archive
Week ahead: Investors hope Royal Mail delivers the goods and Unilever meets targets
The week ahead includes updates from Royal Mail, Unilever, Sports Direct, Rio Tinto and Anglo American along with official UK data on jobs, inflation and retail sales
Advisory committee tells US regulators to reject BTG’s Elevair emphysema treatment
The panel wasn’t convinced that Elevair would have any effect on those taking it, or that the possible benefits outweighed the risks
Investments and investor services
FTSE 100 closes higher but miners hit by Chinese data
Around 3.20pm, the UK blue-chip index was up 17 points to 7,728
Archive
easyJet's losses expected to narrow on back of increased passenger loads
As well as easyJet, updates are expected from big names such as Vodafone, Land Securities and Hargreaves Lansdown.
Archive
Wide variety of blue-chip updates due in coming week - from Centrica to AstraZeneca
Week ahead includes updates from drugs giant AstraZeneca, mobile phones operator Vodafone Group, British Gas-owner Centrica, and postal delivery firm Royal Mail Group
BTG slumps as it takes £150mln impairment for PneumRx Coils in full year results
BTG does not expect material revenues from PneumRx Coils over the next two years
Investments and investor services
FTSE 100 closes in red as traders still jittery about macro issues
The pound is up 0.36% against the Euro at the time of writing, while it is up 0.07% against the US dollar
Archive
Topps Tiles, IAG, easyJet, Electrocomponents and US jobs in focus after Easter break
The week ahead includes interims from Topps Tiles, traffic statistics from easyJet and IAG, a trading statement from Electrocomponents and the US non-farm payrolls report
Archive
Day ahead: ITV, Vodafone and Bovis Homes results, UK inflation data
The day ahead includes corporate earnings from ITV, Vodafone and Bovis Homes as well as official UK inflation data
Archive
Don’t expect fireworks from Taylor Wimpey’s quarterly numbers
House builders and telcos will provide some of the weeks highlights.
BTG takes £55mln hit as court upholds Vistogard ruling
A court in Delaware ruled that the UK firm breached the distribution agreement between the two companies over Vistogard
BTG shares fall after being ordered to pay US$55.8mln in damages in drug distribution dispute
The FTSE 250-listed global healthcare specialist said a court in Delaware had issued the ruling in a case concerning the commercialisation of Vistogard, finding that the British company had breached the distribution agreement
BTG unveils successful trial of deep vein thrombosis treatment
BTG said it has created the only treatment proven to significantly reduce the signs and symptoms of post-thrombotic syndrome
Mayan Energy's shares bounce after update on Shoats Creek project in Louisiana
A look at some of the biggest London-listed risers and fallers today
Archive
Vodafone to post drop in full year revenue and earnings amid rising competition
Vodafone and Speedy Hire report their full year results on Tuesday
Archive
Pension scheme front and centre for Royal Mail Group PLC
Week ahead: Royal Mail, Burberry, SSE, Mitchells and Butlers, easyJet ...
Archive
Proactive news round-up: Avacta Group, Galantas Gold, Aminex …
A glance at some of the stories on the Proactive newswire today
Motif Bio gains as Rodman & Renshaw hikes target price
A look at the top risers and fallers in London on Monday
NetScientific’s portfolio company nets “strong return” from sale of OncoVerse stake
Wanda has offloaded its holding in digital health platform OncoVerse to BTG plc for an undisclosed sum
FTSE 100 closes over 2% higher as France vote cheers
The FTSE 100 closed 150 points, or 2.11% higher, as investors welcomed Macron's result in the first round of France's presidential election
Healthcare specialist BTG expects revenues for year just ended to top its guidance range
Louise Makin, BTG’s CEO, said: "Our business has performed well this year. We have made significant progress in executing our strategy to become a leading provider of Interventional Medicine therapies.”
FTSE 100 stocks hit fresh record before slipping as US stocks turn soft
The FTSE 100 index reached a new peak of 7,211.96 today, exceeding the level it hit on Tuesday, the first session of 2017, and was up 19 points at 7,209 at 3.30pm.
Week Ahead: Royal Mail needs to deliver pre-Christmas surprise
Elsewhere, Crest Nicholson, Barratt Developments, easyJet, Vodafone, TalkTalk and others will all report to the market in one form or another
Funding boost for Sirius Minerals and 88 Energy, but its GAME OVER for Xcite
Suddenly there’s cash swilling around the AIM natural resources sector, but the return of positive sentiment is too little too late for Xcite Energy.
Investments and investor services
Risers & Fallers: Sepura, McColls Retail Group, Hays...
London's rising and falling stocks today at around 4.15pm
Investments and investor services
Preview - Can Vodafone live up to positive expectations?
Vodafone, Speedy Hire and Blinkx are among the highlights in Tuesday's schedule in London.
OR Productivity lines up pre-IPO funding
OR Productivity aims to become a go-to company for the commercialisation of minimally invasive medicine
Archive
Imagination Technologies still a 'buy' despite disappointing interims, says Investec
Never mind the numbers, look at the intellectual property, advises Investec, as it reiterates its 'buy' recommendation of Imagination Technologies.
BTG stumbles after revenue guidance disappointment
Group revenue will be in the lower half of the guidance range of £410mln to £440mln (at an exchange rate of £1:$1.61).